This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: New York University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John K Dickson: Innovator in Therapeutic Agents
Introduction
John K Dickson is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of therapeutic agents. His work focuses on innovative compounds that have the potential to treat diseases related to nicotinamide phosphoribosyltransferase (NAMPT) expression.
Latest Patents
John K Dickson holds a patent for "Fused bicyclic heterocycles as therapeutic agents." This patent relates to compounds and pharmaceutical compositions that can be used for treating diseases associated with NAMPT expression. The disclosure emphasizes the importance of fused bicyclic heterocyclic compounds and outlines methods for inhibiting NAMPT using these innovative compounds.
Career Highlights
John K Dickson is affiliated with New York University, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on therapeutic strategies for various diseases.
Collaborations
Some of his notable coworkers include Andrew S Chi and Xinyan Huang, who contribute to the collaborative research efforts at New York University.
Conclusion
John K Dickson's innovative work in the field of therapeutic agents highlights the importance of research in developing new treatments for diseases. His contributions, particularly through his patent, demonstrate a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile